MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 54 filers reported holding MEDGENICS INC in Q2 2015. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $223,000 | -9.7% | 40,603 | -5.8% | 0.00% | 0.0% |
| Q2 2016 | $247,000 | -42.4% | 43,110 | -51.3% | 0.00% | +100.0% |
| Q1 2016 | $429,000 | -20.3% | 88,568 | -1.9% | 0.00% | 0.0% |
| Q4 2015 | $538,000 | +64.0% | 90,268 | +91.8% | 0.00% | -50.0% |
| Q3 2015 | $328,000 | +10.1% | 47,057 | +0.2% | 0.00% | 0.0% |
| Q2 2015 | $298,000 | -22.8% | 46,947 | -1.6% | 0.00% | 0.0% |
| Q1 2015 | $386,000 | +58.2% | 47,697 | -1.1% | 0.00% | +100.0% |
| Q4 2014 | $244,000 | -1.2% | 48,247 | -5.9% | 0.00% | 0.0% |
| Q3 2014 | $247,000 | -39.3% | 51,268 | -2.1% | 0.00% | -50.0% |
| Q2 2014 | $407,000 | +13.1% | 52,359 | +1.6% | 0.00% | 0.0% |
| Q1 2014 | $360,000 | +8.8% | 51,519 | -6.7% | 0.00% | 0.0% |
| Q4 2013 | $331,000 | -22.5% | 55,204 | -17.8% | 0.00% | -33.3% |
| Q3 2013 | $427,000 | +67.5% | 67,186 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $255,000 | – | 67,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,058,400 | $8,277,000 | 4.07% |
| Belmont Global Advisors, Inc. | 155,000 | $1,212,000 | 2.06% |
| Broadfin Capital, LLC | 1,545,306 | $12,084,000 | 0.67% |
| CARL DOMINO INC | 34,134 | $267,000 | 0.21% |
| QVT Financial LP | 267,608 | $2,093,000 | 0.07% |
| WHITE PINE CAPITAL LLC | 20,000 | $156,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,000 | $931,000 | 0.02% |
| HYMAN CHARLES D | 13,000 | $102,000 | 0.02% |
| Kavar Capital Partners, LLC | 1,500 | $11,000 | 0.01% |
| Brick & Kyle, Associates | 1,000 | $8,000 | 0.01% |